The Nifty 50 fell over 200 points to close at 24,846.25. The broader market was hit harder, with the Nifty Midcap 100 ...

The domestic equity benchmarks opened lower and traded with limited losses in early trade. The Nifty traded below the 25,000 level. Financials, pharma and metal stocks declined while pharma, PSU banks ...

As per provisional closing data, the barometer index, the S&P BSE Sensex, tanked 721.08 points or 0.88% to 81,463.09. The Nifty 50 index declined 225.10 points or 0.90% to 24,837. In two consecutive ...

The key equity indices ended lower for the week, pressured by disappointing earnings, global uncertainty, and sustained foreign institutional investor (FII) outflows. The week began on a strong note, ...

Markets plunge on weak global cues and earnings, with Nifty breaching critical support; pharmaceutical stocks shine amidst ...

Domestic stock markets opened flat amid optimism for the India-UK Free Trade Agreement announcement. Nifty 50 is down by 0.73 ...

The Indian IT sector's Q1 results were mixed, with Infosys performing better than TCS, Wipro, and HCL Tech. The Nifty IT ...

India's stock indices declined in early trading on Friday, pulled down by Bajaj Finance due to worries over asset quality, as ...

Markets open weak as Sensex and Nifty decline, facing headwinds from FII outflows, weak earnings, and trade uncertainties.

Benchmark indices Nifty and Sensex opened sharply lower on July 25, dragged down by weak cues from Asian markets despite ...

Cipla share price gain 3% after Q1 earnings beat estimates, with strong margins, India growth, and positive analyst sentiment ...

Cipla , India's third-largest drugmaker by sales, reported a better-than-expected quarterly profit on Friday, driven by higher domestic demand for its generic respiratory drugs.